You searched for "legal"
Is there a role for hyperbaric treatment in sudden hearing loss?
Sudden sensorineural hearing loss is a common presentation to ENT departments with a significant difference in management both at a local and regional level. The authors seek to clarify the role of hyperbaric oxygen therapy in combination with oral and...From the editor MayJun 2022
Declan Costello, MA, MBBS, FRCS(ORL-HNS), Editor, ENT & Audiology News; Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.net The horrifying situation in Ukraine has drawn international condemnation of the Russian government; as a consequence,...From the editor JulyAugust 2022
Declan Costello, MA, MBBS, FRCS(ORL-HNS), Editor, ENT & Audiology News; Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.net One of the joys of attending meetings and conferences is the chance to catch up with...From the editor January/February 2023
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTw: @Voicedoctor_uk As we start 2023, it’s a pleasure to wish you a Happy New Year. We have much to look forward to...CEORL-HNS observership travel grants
The Confederation of European ORL-HNS has announced a set of grants and scholarships for 2024.Prof Quraishi OBE awarded Fellowship ad hominem FRCSEd
At a presentation ceremony on Friday 3 September, President of the Royal College of Surgeons of Edinburgh (FRCSEd), Prof Michael Griffin OBE, welcomed the members of the Council, fresh diplomates, their families and other guests. This was the first conferring...The delivery of ENT services in Mongolia: what are its obstacles?
Globally, the burden of ENT disease is great. Disabling hearing loss (DHL) for example, is reported to affect half a billion people worldwide. The majority of afflicted individuals live in lower and middle-income countries (LMIC) [1]. This article, a collaboration...COOL therapy for cisplatin-induced hearing loss
Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...
What should be considered a ‘close’ margin in oral cavity squamous cell carcinoma?
Achieving clear margins during surgical resection in oral cavity squamous cell carcinoma (OCSCC) is thought to reduce local recurrence (LR) and improve prognosis; however, what constitutes a clear, close, or involved margin is inconsistent in the literature and in practice....
